Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,009 public trials 2,035 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00053768

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • Specialist Practice for Oncology Aschaffenburg, Germany
View all 175 locations
View Trial Details
Completed

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

NCT02500550

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +18 more
Locations
  • Algemeen Ziekenhuis Sint-Jan Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Universitair Ziekenhuis Gasthuisberg Leuven, Belgium
  • Centre Hospitalier Universitaire de Liège Liège, Belgium
View Trial Details
Completed

A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)

NCT01100502

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 87 locations
View Trial Details
Completed

GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)

NCT01419665

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Investigative site La Plata, Argentina
  • Investigative site Rosario, Argentina
  • Investigative site San Miguel de Tucumán, Argentina
  • Investigative site Adelaide, Australia
View all 153 locations
View Trial Details
Completed

FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma

NCT01410630

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • MD Anderson Cancer Center - University of Texas Houston, Texas, United States
  • Aachen University Aachen, Germany
View Trial Details
Completed

Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

NCT01018979

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations
  • Chang-Gung Memorial Hospital Chiayi Chiayi City, Taiwan
  • Buddist Tzu Chi General Hospital Hualien City, Taiwan
  • Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
  • Chang-Gung Memorial Hospital Linkou Linkou District, Taiwan
View Trial Details

Related conditions